Finance

Lists
Why is QCORE down 7.49%?
Dive Deeper
QCORE:STO
Qlucore publ AB
SEK 0.32
-7.49%
(-0.026) 1D
Oct 16, 5:00:00 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for QCORE...
Open
SEK 0.32
High
SEK 0.36
Low
SEK 0.32
Mkt. cap
13.65M
Avg. vol.
13.92K
Volume
4.72K
52-wk high
SEK 0.58
52-wk low
SEK 0.21
EPS
-SEK 1.64
Shares outstanding
42.90M
No. of employees
12
Open
SEK 0.32
High
SEK 0.36
Low
SEK 0.32
Mkt. cap
13.65M
Avg. vol.
13.92K
Volume
4.72K
52-wk high
SEK 0.58
52-wk low
SEK 0.21
EPS
-SEK 1.64
Shares outstanding
42.90M
No. of employees
12
News stories
From web sources and news partners
Profile
Qlucore is a Swedish Bioinformatics software company founded in the year 2007. It started as a collaborative research project at Lund University, Sweden, supported by researchers at the Departments of Mathematics and Clinical Genetics. The objective was to address the vast amount of high-dimensional data generated with microarray gene expression analysis. To this end, it was imperative to have an interactive scientific software tool necessary for the conceptualize ideas emanating from the research collaborations. Since then, a new version of the software has been released approximately every nine months. In 2017, Qlucore took a major step in the technology by adding the NGS module including a dynamic and fast Genome browser to enable analysis of data being generated with Next Generation Sequencing technologies. Qlucore Omics Explorer is a visualisation based software program that provides for the exploration and visualization of big data. This enables researchers to analyze and explore large data sets on a regular PC or Mac. Qlucore Omics Explorer customers are mainly from the Life Science, Plant, Food, and Biotech industries and from matching academic research areas. Wikipedia
About Qlucore publ AB
CEO-
Employees12
FoundedJan 15, 2007
Headquarters-
SectorHealth care
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
1.79M
2.19M
5.57M
1.70M
Cost of goods sold
3.79M
4.26M
3.70M
3.29M
Cost of revenue
3.79M
4.26M
3.70M
3.29M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.11M
5.17M
3.04M
2.70M
Operating expense
21.14M
1.16M
5.32M
1.24M
Total operating expenses
24.93M
5.43M
9.01M
4.53M
Operating income
-23.14M
-3.24M
-3.44M
-2.83M
Other non operating income
1.00K
-
-
-
EBT including unusual items
-23.21M
-3.31M
-3.38M
-2.86M
EBT excluding unusual items
-23.21M
-3.31M
-3.38M
-2.86M
Income tax expense
5.00K
5.00K
-2.00K
4.00K
Effective tax rate
-0.02%
-0.15%
0.06%
-0.14%
Other operating expenses
16.90M
-5.68M
669.00K
-3.06M
Net income
-23.21M
-3.31M
-3.38M
-2.86M
Net profit margin
-1,295.31%
-151.19%
-60.71%
-167.96%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
8.00K
61.00K
12.00K
Interest expense
-74.00K
-76.00K
-
-42.00K
Net interest expenses
-73.00K
-68.00K
61.00K
-30.00K
Depreciation and amortization charges
2.13M
1.67M
1.60M
1.60M
EBITDA
-21.00M
-1.57M
-1.84M
-1.23M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps